Alzheimer's Therapies, Market Cap Analysis, and Stock Concentration Trends

Exploring the safety concerns of Dononimab and Lekimbi in treating Alzheimer's, along with Nvidia's $3 trillion market cap and the evolution of top US stock market stocks.

Play episode from 04:09

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app